SHIH-HUNG YANGSUNG-HSIN KUO2021-02-232021-02-2320080939-5555https://www.scopus.com/inward/record.uri?eid=2-s2.0-41249094005&doi=10.1007%2fs00277-007-0396-1&partnerID=40&md5=28b9ae314214bfd3e058eae033638450https://scholars.lib.ntu.edu.tw/handle/123456789/549494[SDGs]SDG3aminotransferase; chlorambucil; hepatitis B surface antigen; hepatitis B(e) antigen; immunoglobulin G antibody; immunoglobulin M antibody; lamivudine; rituximab; virus antibody; virus DNA; adult; case report; female; follicular lymphoma; hepatitis B; Hepatitis B virus; human; letter; leukocyte count; leukopenia; liver function test; lymphadenopathy; monotherapy; nonhuman; priority journal; remission; virus reactivation; Adult; Antibodies, Monoclonal; Antineoplastic Agents; Female; Hepatitis B; Hepatitis B virus; Humans; Immunologic Factors; Liver Function Tests; Lymphoma, Follicular; Neoplasm Staging; Treatment Outcome; Virus Activationletter10.1007/s00277-007-0396-1179326712-s2.0-41249094005